Related Experiment Video

Updated: Oct 4, 2025

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

7.0K

New Classification Criteria for Small-Vessel Vasculitis: Is Antineutrophil Cytoplasmic Antibody Inclusion Their Major

Christian Dejaco1, Loïc Guillevin2

  • 1Medical University of Graz, Graz, Austria, and Hospital of Brunico (SABES-ASDAA), Brunico, Italy.

Arthritis & Rheumatology (Hoboken, N.J.)
|February 2, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

135.6K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K

Related Experiment Videos

Last Updated: Oct 4, 2025

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

7.0K
Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

135.6K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

52
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
52
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

33
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
33

Articles linked to this work by shared authors, journal, and citation graph.

Study on the implementation of the 2015 EULAR/ACR recommendations for polymyalgia rheumatica in clinical practice.

RMD open·2026

[Polymyalgia rheumatica].

Zeitschrift fur Rheumatologie·2026

Ultrasound-based withdrawal of biologics in rheumatoid arthritis (RA-BioStop).

RMD open·2026

Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS study.

Rheumatology (Oxford, England)·2026

Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids.

Nature reviews. Rheumatology·2026

Patient experiences of PMR: a qualitative narrative literature review.

Rheumatology advances in practice·2026

EXPRESSION OF CONCERN: Induction of Scleroderma Fibrosis in Skin-humanized Mice by Administration of Anti-platelet-derived Growth Factor Receptor Agonistic Autoantibodies.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Tph and Tfh cells as biomarkers and targets in rheumatic diseases.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Outcomes of Tapering Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Multicenter Randomized Noninferiority Trial.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Mesenchymal Stromal Cells Fuel Immunometabolic Reprogramming of Type 2 Conventional Dendritic Cells to Alleviate Systemic Sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

The association between systemic inflammation as measured by calprotectin and autoantibody load in rheumatoid arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Oral glucocorticoid dose patterns and organ damage in systemic lupus erythematosus - a nationwide cohort study.

Arthritis & rheumatology (Hoboken, N.J.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us